Seeking Alpha

Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific ...

SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...
Jazz

Aardvark Jazz Orchestra

Founded in 1973, The Aardvark Jazz Orchestra has been a force in the international jazz scene for more than 50 years. Aardvark is one of the longest-running large jazz ensembles in the world. The band ...
Seeking Alpha

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...
Business Insider

Aardvark Therapeutics Announces Leadership Appointments

SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...
The Globe and Mail

Aardvark Therapeutics Announces Establishment of New U.S. Subsidiary to Support Development ...

SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...
Nasdaq

Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and ...

Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome, further guidance on the program expected in Q2 2026 ...